Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion

EHRs + Genomics = Drugs? – An opinionated take on NEJM highlights for March 2018

  • NEJM
GWAS, Regeneron and Geisinger, and liver disease Genome wide associati…

Read more